| Literature DB >> 35832499 |
Ting-Yu Tu1, Chih-Yang Hsu2, Pei-Chin Lin3,4, Chun-Yu Chen1,5,6.
Abstract
Background: Distal radius fractures are treated using open reduction and internal fixation and using general anesthesia (GA) or regional blocks. A new technique, wide-awake local anesthesia with no tourniquet (WALANT), allows this operation to be conducted in nonsedated patients without the use of tourniquets. Objective: We analyzed whether WALANT yields better outcomes than GA in the treatment of patients with distal radius fractures. Evidence Review: We searched the PubMed, Cochrane Library, Embase, and Scopus databases for cases of distal radius fractures treated using WALANT or GA. The outcomes of interest were duration of preparation for surgery, duration of surgery, blood loss, and length of postoperative hospitalization; visual analog scale (VAS), Mayo wrist score, and Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire score on postoperative day 1; range of motion (ROM); time until bone union; and complication rate. Findings: We systematically reviewed 4 studies with a total of 263 patients (128 with WALANT and 135 with GA). In comparison with GA, WALANT required less time for preparation for surgery, shorter postoperative hospitalization, and lower postoperative day 1 VAS scores; however, blood loss was greater. Functional outcomes (ROM, QuickDASH score, and Mayo wrist score), complication rates, and times until union did not differ considerably between the two methods.Entities:
Keywords: GA; WALANT; distal radius; fixation; fracture; general anesthesia; wide-awake local anesthesia no tourniquet
Year: 2022 PMID: 35832499 PMCID: PMC9271796 DOI: 10.3389/fsurg.2022.922135
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1PRISMA flow diagram of study selection.
Demographic characteristics of the studies included in the systematic review.
| Study | Type | Intervention | Size (M/F) | Follow-up | Age (mean ± SD) | Fracture pattern (number of patients) | Inclusion criteria | Exclusion criteria | WALANT solution | Injection | Postoperative medication | Approach | Implant choice |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Huang et al. (2019) ( | RCS | WALANT | 21 (8/13) | 1 y | 65.29 ± 15.47 | A2 (3), A3 (6), B2 (5), C1 (3), C2 (4) | Acute traumatic injury, closed, unilateral distal radius fractures | Associated injury in other organs | 5–10 mL 1% lidocaine + 1:40,000 epinephrine | 3–5 mL 1% lidocaine hematoma block → WALANT solution injected on volar side of DR → 5 mL WALANT solution beneath PQ | Tramadol, 37.5 mg/325 mg; acetaminophen twice/day | Henry | Volar locking Plate (2.4 mm LCP Distal Radius system, Synthes) |
| GA | 26 (9/17) | 62.31 ± 14.42 | A2 (9), A3 (5), B2 (2), C1 (1), C2 (8), C3 (1) | NA | 230 mg Hg tourniquet | ||||||||
| Tahir et al. (2020) ( | RCT | WALANT | 55 (31/24) | 2 and 6 wk, 1 y | 46.6 ± 10.91 | A2 (6), A3 (5), B1 (11), B3 (5), C1 (7), C2 (15), C3 (6) | Isolated closed fracture of the distal radius within 10 days |
Open fracture of the distal radius Bilateral distal radius fracture Active infection in the body Contraindication for WALANT
Noncooperative patients Bleeding tendency Hypersensitive to lidocaine Polytrauma patients | 0.9% normal saline + 2% lidocaine + 1:100,000 epinephrine | 3–5 mL 2% lidocaine hematoma block → WALANT solution injected on four skin points where 2 cm apart from the distal wrist crease → additional 5 mL WALANT solution beneath PQ | Tramadol, 37.5 mg/325 mg; acetaminophen, twice/day; calcium supplements | Henry | Volar Locking plates (Double medical Technologies, Fujian, China) |
| GA | 56 (28/28) | 49.7 ± 9.3 | A2 (5), A3 (7), B1 (6), B3 (9), C1 (7), C2 (9), C3 (13) | NA | 250 mg Hg tourniquet | ||||||||
| Yi et al. (2020) ( | RCS | WALANT | 20 (19/1) | 4 wk | 41.7 ± 16.37 | A2 (1), A3 (2), B1 (1), B2 (2), B3 (5), C1 (3), C2 (4), C3 (2) | Distal radius fracture | NA | 50 mL 0.9% normal saline + 50 mL lidocaine HCl 2% + 1 mL adrenaline acid tartrate 0.18% 1 mg/mL + 10 mL sodium bicarbonate 8.4% | WALANT solution injected subcutaneously along the modified Henry skin incision, 1 cm beyond the incision site and three dots | NA | Modified Henry | Volar Plating |
| GA | 20 (10/10) | 44.3 ± 17.63 | A2 (1), A3 (4), B1 (2), B2 (3), B3 (3), C1 (2), C2 (3), C3 (2) | NA | NA | ||||||||
| Hamid et al. (2021) ( | RCT | WALANT | 32 (21/11) | 3 and 6 wk, 3 and 6 mo | 47.19 ± 8.19 | A2 (9), A3 (2), B1 (2), B2 (2), B3 (6), C1 (3), C2 (6), C3 (2) | Distal radius fracture | Peripheral vascular disease | 50 mL of normal saline + 50 mL of lidocaine 2% +1 mL of 1:1,000 adrenaline solution + 10 mL of 8.4% sodium bicarbonate | 10 mL of WALANT solution injected subcutaneously along the modified Henry skin incision, 30 mL was injected into the periosteal layer at three dots | Tramadol, 50 mg three times a day; paracetamol, 1,000 mg four times a day | Modified Henry | Volar Plating |
| GA | 33 | 49.48 ± 6.02 | A2 (6), A3 (2), B1 (3), B2 (6), B3 (2), C1 (2), C2 (9), C3 (3) | NA | NA |
WALANT, wide-awake local anesthesia and no tourniquet; RCS, Retrospective cohort study; DR, distal radius; PQ, pronator quadratus; GA, general anesthesia; RCT, Randomized controlled trial; NA, not applicable.
At each dot, 10 mL of the WALANT solution was injected at different angles into the volar (4 mL), lateral (2 mL) and posterior (4 mL) aspects of the radius within the periosteal layer.
Patients’ outcomes presented in the studies.
| Study | Intervention | Size | Preparation time, min (mean ± SD) | Surgery time, min (mean ± SD) | Blood loss, mL (mean ± SD) | Post-operation Day 1 VAS (mean ± SD) | Postoperative hospital stay, days (mean ± SD) | Union time, wk (mean ± SD) | Extension (mean ± SD) | Flexion (mean ± SD) | Mayo wrist score (mean ± SD) | QuickDASH score (mean ± SD) | Complication (case / total) | Revision ( |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Huang et al. (2019) ( | WALANT | 21 | 25.38 ± 4.59 | 68.10 ± 9.28 | 22.62 ± 6.82 | 1.95 ± 0.67 | 1.38 ± 0.5 | 20.76 ± 4.35 | 50.24 ± 9.28 | 67.14 ± 9.95 | 86.67 ± 7.13 | NA | 0 / 21 | 0 |
| GA | 26 | 37.31 ± 11.16 | 64.42 ± 10.42 | 8.62 ± 9.23 | 3.27 ± 1.28 | 2.46 ± 0.71 | 22.46 ± 4.17 | 49.42 ± 6.22 | 71.35 ± 8.19 | 84.04 ± 7.35 | 0 / 26 | 0 | ||
| Tahir et al. (2020) ( | WALANT | 55 | 23.0 ± 3.85 | 61.30 ± 9.28 | 23.40 ± 8.50 | 1.20 ± 0.62 | 0.20 ± 0.50 | 15.3 ± 2.31 | 54.8 ± 6.45 | 65.9 ± 6.01 | 86.3 ± 5.08 | 10.2 ± 2.80 | 0 / 55 | 0 |
| GA | 56 | 33.7 ± 5.81 | 68.80 ± 14.97 | 11.50 ± 4.25 | 3.00 ± 1.24 | 1.20 ± 0.78 | 15.8 ± 2.54 | 52.9 ± 4.45 | 64.3 ± 4.47 | 87.3 ± 5.13 | 10.2 ± 2.99 | 3 / 56 | 0 | |
| Yi et al. (2020) ( | WALANT | 20 | NA | 86 ( | 49 ( | NA | 1 ( | NA | NA | NA | NA | NA | 1 / 20 | 1 |
| GA | 20 | 102 | 63 | 2 | 3 / 20 | 0 | ||||||||
| Hamid et al. (2021) ( | WALANT | 32 | NA | 61.22 ± 7.72 | 14.88 ± 5.29 | 2.66 ± 0.60 | NA | NA | 70.47 ± 8.17 | 72.81 ± 7.18 | NA | 4.09 ± 0.89 | 0 / 32 | 0 |
| GA | 33 | 55.30 ± 7.90 | 13.03 ± 2.78 | 2.85 ± 0.80 | 71.36 ± 5.63 | 74.55 ± 5.64 | 4.45 ± 0.87 | 2 / 33 | 2 |
SD, standard deviation; VAS, visual analog scale; QuickDASH, Quick Disabilities of the Arm, Shoulder and Hand questionnaire; WALANT, wide-awake local anesthesia and no tourniquet; GA, general anesthesia; NA, not applicable.
Figure 2(Continued)
Risk of bias assessment of included studies.
| Study | Newcastle–Ottawa scale | Selection bias | Comparability bias | Outcome bias | Quality | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Outcome of interest was not present at start of study | Comparability of cohorts on the design | Assessment of outcome | Follow-up long enough for outcomes to occur | Adequacy of follow-up of cohorts | |||
| Huang et al. (2019) ( | RCS | * | * | * | * | * | * | * | * | High |
| Yi et al. (2020) ( | RCS | * | * | * | * | * | * | * | * | High |
|
|
|
|
|
|
|
|
|
| ||
|
|
| |||||||||
| Tahir et al. (2020) ( | RCT | Low | Low | Low | High | Low | Low | Low | High | |
| Hamid et al. (2021) ( | RCT | Low | Unclear | Unclear | High | Unclear | Low | Low | High | |
On Newcastle–Ottawa scale, high quality: 8–9 stars (*), moderate quality: 5–7 stars (*), low quality: <5 stars (*).
RCS, Retrospective cohort study; RCT, Randomized controlled trial; ROB, The Cochrane Collaboration’s Risk of Bias Tool.